TNFSF13B and systemic lupus erythematosus: In systemic lupus erythematosus refractory to B cell depletion, cyclophosphamide and several immunosuppressive drugs, daratumumab was effective and clinical responses sustained by anti-BAFF (belimumab) maintenance treatment (58).